ALNY
Alnylam Pharmaceuticals Inc
$225.30
3.17 (1.42%) Today
1.82 (0.80%) After-hours
— up— down
Market Cap
$29.97B-47.5%
Revenue (TTM)
$4.64B+95.1%
Net Income (TTM)
$784.45M
$784.45MEPS (TTM)
5.88
5.88Shares Out
133.51M
133.51MP/E Ratio
37.09
37.09Forward P/E
22.49
22.49Open
$225.95
$225.95Previous Close
$223.95
$223.95Day Range
$222.70 – $227.54
$222.70 – $227.5452-Week Range
$197.81 – $495.55
$197.81 – $495.55Beta
0.25
0.25Volume
1.42M
1.42MAvg Volume
1.46M
1.46MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout ALNY
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.
